Vectors for pulmonary gene therapy

International Journal of Pharmaceutics

Volumn 390, Issue 1, 2010, Pages 84-88

  Geiger, J ^a,b   Aneja, M K ^a   Rudolph, C ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Gene therapy; Lung; Nanocarriers; Non viral vectors; Viral vectors

Indexed keywords

ADENOVIRUS VECTOR; CATION; LENTIVIRUS VECTOR; LIPID; LIPOPLEX; NAKED DNA; PLASMID DNA; POLY[2 (DIMETHYLAMINO)ETHYL METHACRYLATE]; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; SENDAI VIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

AIRWAY; ARTICLE; CLINICAL TRIAL; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HUMAN; LUNG; NONHUMAN; NONVIRAL GENE THERAPY; PHENOTYPE; PRIORITY JOURNAL; TRANSGENE; VIRAL GENE THERAPY; ANIMAL; GENETICS; LUNG DISEASES; PROCEDURES;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG DISEASES; GENETIC THERAPY;

EID: 77951256303     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.10.010     Document Type: Article

References (90)

1. Aneja M.K., Imker R., Rudolph C. Phage phiC31 integrase-mediated genomic integration and long-term gene expression in the lung after nonviral gene delivery. J. Gene Med. 2007, 9:967-975.
2. Barron L.G., Gagne L., Szoka F.C. Lipoplex-mediated gene delivery to the lung occurs within 60minutes of intravenous administration. Hum. Gene Ther. 1999, 10:1683-1694.
3. Belur L.R., Frandsen J.L., Dupuy A.J., Ingbar D.H., Largaespada D.A., Hackett P.B., Scott Mcivor R. Gene insertion and long-term expression in lung mediated by the sleeping beauty transposon system. Mol. Ther. 2003, 8:501-507.
4. Bragonzi A., Dina G., Villa A., Calori G., Biffi A., Bordignon C., Assael B.M., Conese M. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther. 2000, 7:1753-1760.
5. Breeze R.G., Wheeldon E.B. The cells of the pulmonary airways. Am. Rev. Respir. Dis. 1977, 116:705-777.
6. Buckley S.M., Howe S.J., Sheard V., Ward N.J., Coutelle C., Thrasher A.J., Waddington S.N., Mckay T.R. Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression. Gene Ther. 2008, 15:1167-1175.
7. Cao H., Koehler D.R., Hu J. Adenoviral vectors for gene replacement therapy. Viral Immunol. 2004, 17:327-333.
8. Chen Z.Y., He C.Y., Meuse L., Kay M.A. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther. 2004, 11:856-864.
9. Davies L.A., Mclachlan G., Sumner-Jones S.G., Ferguson D., Baker A., Tennant P., Gordon C., Vrettou C., Baker E., Zhu J., Alton E.W., Collie D.D., Porteous D.J., Hyde S.C., Gill D.R. Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol. Ther. 2008, 16:1283-1290.
10. Davis P.B., Cooper M.J. Vectors for airway gene delivery. AAPS J. 2007, 9:E11-E17.
11. Dean D.A., Machado-Aranda D., Blair-Parks K., Yeldandi A.V., Young J.L. Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther. 2003, 10:1608-1615.
12. Densmore C.L., Orson F.M., Xu B., Kinsey B.M., Waldrep J.C., Hua P., Bhogal B., Knight V. Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization. Mol. Ther. 2000, 1:180-188.
13. Dif F., Djediat C., Alegria O., Demeneix B., Levi G. Transfection of multiple pulmonary cell types following intravenous injection of PEI-DNA in normal and CFTR mutant mice. J. Gene Med. 2006, 8:82-89.
14. Elfinger M., Geiger J., Hasenpusch G., Uzgun S., Sieverling N., Aneja M.K., Maucksch C., Rudolph C. Targeting of the beta(2)-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo. J. Control Release 2009, 135:234-241.
15. Elfinger M., Maucksch C., Rudolph C. Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials 2007, 28:3448-3455.
16. Ernst N., Ulrichskotter S., Schmalix W.A., Radler J., Galneder R., Mayer E., Gersting S., Plank C., Reinhardt D., Rosenecker J. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant. J. Gene Med. 1999, 1:331-340.
17. Faneca H., Simoes S., Pedroso De Lima M.C. Association of albumin or protamine to lipoplexes: enhancement of transfection and resistance to serum. J. Gene Med. 2004, 6:681-692.
18. Ferrari S., Griesenbach U., Iida A., Farley R., Wright A.M., Zhu J., Munkonge F.M., Smith S.N., You J., Ban H., Inoue M., Chan M., Singh C., Verdon B., Argent B.E., Wainwright B., Jeffery P.K., Geddes D.M., Porteous D.J., Hyde S.C., Gray M.A., Hasegawa M., Alton E.W. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther. 2007, 14:1371-1379.
19. Flotte T.R. Adeno-associated virus-based gene therapy for inherited disorders. Pediatr. Res. 2005, 58:1143-1147.
20. Gill D.R., Davies L.A., Pringle I.A., Hyde S.C. The development of gene therapy for diseases of the lung. Cell. Mol. Life Sci. 2004, 61:355-368.
21. Gill D.R., Smyth S.E., Goddard C.A., Pringle I.A., Higgins C.F., Colledge W.H., Hyde S.C. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther. 2001, 8:1539-1546.
22. Goldman M.J., Lee P.S., Yang J.S., Wilson J.M. Lentiviral vectors for gene therapy of cystic fibrosis. Hum. Gene Ther. 1997, 8:2261-2268.
23. Gorecki D.C. Prospects and problems of gene therapy: an update. Expert Opin. Emerg. Drugs 2001, 6:187-198.
24. Goula D., Becker N., Lemkine G.F., Normandie P., Rodrigues J., Mantero S., Levi G., Demeneix B.A. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther. 2000, 7:499-504.
25. Griesenbach U., Chonn A., Cassady R., Hannam V., Ackerley C., Post M., Tanswell A.K., Olek K., O'brodovich H., Tsui L.C. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy. Gene Ther. 1998, 5:181-188.
26. Griesenbach U., Geddes D.M., Alton E.W. Gene therapy for cystic fibrosis: an example for lung gene therapy. Gene Ther. 2004, 11:S43-50.
27. Grubb B.R., Pickles R.J., Ye H., Yankaskas J.R., Vick R.N., Engelhardt J.F., Wilson J.M., Johnson L.G., Boucher R.C. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 1994, 371:802-806.
28. Guillaume-Gable C., Floch V., Mercier B., Audrezet M.P., Gobin E., Le Bolch G., Yaouanc J.J., Clement J.C., Des Abbayes H., Leroy J.P., Morin V., Ferec C. Cationic phosphonolipids as nonviral gene transfer agents in the lungs of mice. Hum. Gene Ther. 1998, 9:2309-2319.
29. Haas J., Ravi Kumar M.N., Borchard G., Bakowsky U., Lehr C.M. Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers. AAPS PharmSciTech 2005, 6:E22-E30.
30. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., Mccormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J.I., De Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L.E., Wissler M., Prinz C., Rabbitts T.H., Le Deist F., Fischer A., Cavazzana-Calvo M. Lmo2-associated clonal T cell proliferation in two patients after gene therapy for Scid-X1. Science 2003, 302:415-419.
31. Halbert C.L., Allen J.M., Miller A.D. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol. 2001, 75:6615-6624.
32. Halbert C.L., Rutledge E.A., Allen J.M., Russell D.W., Miller A.D. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 2000, 74:1524-1532.
33. Hamilton H., Gomos J., Berns K.I., Falck-Pedersen E. Adeno-associated virus site-specific integration and AAVS1 disruption. J. Virol. 2004, 78:7874-7882.
34. Hartigan-O'connor D., Barjot C., Salvatori G., Chamberlain J.S. Generation and growth of gutted adenoviral vectors. Methods Enzymol. 2002, 346:224-246.
35. Harvey B.G., Leopold P.L., Hackett N.R., Grasso T.M., Williams P.M., Tucker A.L., Kaner R.J., Ferris B., Gonda I., Sweeney T.D., Ramalingam R., Kovesdi I., Shak S., Crystal R.G. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Invest. 1999, 104:1245-1255.
36. Harvey B.G., Maroni J., O'donoghue K.A., Chu K.W., Muscat J.C., Pippo A.L., Wright C.E., Hollmann C., Wisnivesky J.P., Kessler P.D., Rasmussen H.S., Rosengart T.K., Crystal R.G. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum. Gene Ther. 2002, 13:15-63.
37. Hyde S.C., Pringle I.A., Abdullah S., Lawton A.E., Davies L.A., Varathalingam A., Nunez-Alonso G., Green A.M., Bazzani R.P., Sumner-Jones S.G., Chan M., Li H., Yew N.S., Cheng S.H., Boyd A.C., Davies J.C., Griesenbach U., Porteous D.J., Sheppard D.N., Munkonge F.M., Alton E.W., Gill D.R. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol. 2008, 26:549-551.
38. Hyde S.C., Southern K.W., Gileadi U., Fitzjohn E.M., Mofford K.A., Waddell B.E., Gooi H.C., Goddard C.A., Hannavy K., Smyth S.E., Egan J.J., Sorgi F.L., Huang L., Cuthbert A.W., Evans M.J., Colledge W.H., Higgins C.F., Webb A.K., Gill D.R. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 2000, 7:1156-1165.
39. Joseph P.M., O'sullivan B.P., Lapey A., Dorkin H., Oren J., Balfour R., Perricone M.A., Rosenberg M., Wadsworth S.C., Smith A.E., St George J.A., Meeker D.P. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications. Hum. Gene Ther. 2001, 12:1369-1382.
40. Kihara F., Arima H., Tsutsumi T., Hirayama F., Uekama K. In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjug. Chem. 2003, 14:342-350.
41. Kloeckner J., Boeckle S., Persson D., Roedl W., Ogris M., Berg K., Wagner E. DNA polyplexes based on degradable oligoethylenimine-derivatives: combination with EGF receptor targeting and endosomal release functions. J. Control Release 2006, 116:115-122.
42. Kobayashi M., Iida A., Ueda Y., Hasegawa M. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J. Virol. 2003, 77:2607-2614.
43. Kobinger G.P., Weiner D.J., Yu Q.C., Wilson J.M. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 2001, 19:225-230.
44. Konstan M.W., Davis P.B., Wagener J.S., Hilliard K.A., Stern R.C., Milgram L.J., Kowalczyk T.H., Hyatt S.L., Fink T.L., Gedeon C.R., Oette S.M., Payne J.M., Muhammad O., Ziady A.G., Moen R.C., Cooper M.J. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum. Gene Ther. 2004, 15:1255-1269.
45. Koping-Hoggard M., Varum K.M., Issa M., Danielsen S., Christensen B.E., Stokke B.T., Artursson P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 2004, 11:1441-1452.
46. Kukowska-Latallo J.F., Raczka E., Quintana A., Chen C., Rymaszewski M., Baker J.R. Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Hum. Gene Ther. 2000, 11:1385-1395.
47. Lee T.W., Matthews D.A., Blair G.E. Novel molecular approaches to cystic fibrosis gene therapy. Biochem. J. 2005, 387:1-15.
48. Li S., Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 1997, 4:891-900.
49. Limberis M.P., Vandenberghe L.H., Zhang L., Pickles R.J., Wilson J.M. Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol. Ther. 2009, 17:294-301.
50. Limberis M.P., Wilson J.M. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12993-12998.
51. Liu X., Luo M., Guo C., Yan Z., Wang Y., Lei-Butters D.C., Engelhardt J.F. Analysis of adeno-associated virus progenitor cell transduction in mouse lung. Mol. Ther. 2009, 17:285-293.
52. Luten J., Van Nostrum C.F., De Smedt S.C., Hennink W.E. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Control Release 2008, 126:97-110.
53. Marshall J., Nietupski J.B., Lee E.R., Siegel C.S., Rafter P.W., Rudginsky S.A., Chang C.D., Eastman S.J., Harris D.J., Scheule R.K., Cheng S.H. Cationic lipid structure and formulation considerations for optimal gene transfection of the lung. J. Drug Target 2000, 7:453-469.
54. Mctaggart S., Al-Rubeai M. Retroviral vectors for human gene delivery. Biotechnol. Adv. 2002, 20:1-31.
55. Noone P.G., Hohneker K.W., Zhou Z., Johnson L.G., Foy C., Gipson C., Jones K., Noah T.L., Leigh M.W., Schwartzbach C., Efthimiou J., Pearlman R., Boucher R.C., Knowles M.R. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol. Ther. 2000, 1:105-114.
56. Oudrhiri N., Vigneron J.P., Peuchmaur M., Leclerc T., Lehn J.M., Lehn P. Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1651-1656.
57. Palmer D.J., Ng P. Helper-dependent adenoviral vectors for gene therapy. Hum. Gene Ther. 2005, 16:1-16.
58. Papanicolaou I., Briggs S., Alpar H.O. Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer. J. Drug Target. 2004, 12:541-547.
59. Park T.G., Jeong J.H., Kim S.W. Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev. 2006, 58:467-486.
60. Perricone M.A., Morris J.E., Pavelka K., Plog M.S., O'sullivan B.P., Joseph P.M., Dorkin H., Lapey A., Balfour R., Meeker D.P., Smith A.E., Wadsworth S.C., St George J.A. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium. Hum. Gene Ther. 2001, 12:1383-1394.
61. Ravi Kumar M.N., Sameti M., Mohapatra S.S., Kong X., Lockey R.F., Bakowsky U., Lindenblatt G., Schmidt H., Lehr C.M. Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. J. Nanosci. Nanotechnol. 2004, 4:876-881.
62. Rosenecker J., Naundorf S., Gersting S.W., Hauck R.W., Gessner A., Nicklaus P., Muller R.H., Rudolph C. Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins. J. Gene Med. 2003, 5:49-60.
63. Rudolph C., Lausier J., Naundorf S., Muller R.H., Rosenecker J. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J. Gene Med. 2000, 2:269-278.
64. Rudolph C., Schillinger U., Ortiz A., Plank C., Golas M.M., Sander B., Stark H., Rosenecker J. Aerosolized nanogram quantities of plasmid DNA mediate highly efficient gene delivery to mouse airway epithelium. Mol. Ther. 2005, 12:493-501.
65. Ruiz F.E., Clancy J.P., Perricone M.A., Bebok Z., Hong J.S., Cheng S.H., Meeker D.P., Young K.R., Schoumacher R.A., Weatherly M.R., Wing L., Morris J.E., Sindel L., Rosenberg M., Van Ginkel F.W., Mcghee J.R., Kelly D., Lyrene R.K., Sorscher E.J. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum. Gene Ther. 2001, 12:751-761.
66. Schaffert D., Wagner E. Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther. 2008, 15:1131-1138.
67. Seiler M.P., Miller A.D., Zabner J., Halbert C.L. Adeno-associated virus types 5 and 6 use distinct receptors for cell entry. Hum. Gene Ther. 2006, 17:10-19.
68. Shirohzu H.M.K, Tabata T., et al. 495. Efficient in vivo transduction of mouse airway epithelial cells by simian immunodeficiency virus vector pseudotyped with sendai virus F and HN proteins. Mol. Ther. 2004, 9:188-1188.
69. Sidi A.A., Ohana P., Benjamin S., Shalev M., Ransom J.H., Lamm D., Hochberg A., Leibovitch I. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J. Urol. 2008, 180:2379-2383.
70. Simon R.H., Engelhardt J.F., Yang Y., Zepeda M., Weber-Pendleton S., Grossman M., Wilson J.M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum. Gene Ther. 1993, 4:771-780.
71. Smith R.H. Adeno-associated virus integration: virus versus vector. Gene Ther. 2008, 15:817-822.
72. St George J.A. Gene therapy progress and prospects: adenoviral vectors. Gene Ther. 2003, 10:1135-1141.
73. Tagalakis A.D., Mcanulty R.J., Devaney J., Bottoms S.E., Wong J.B., Elbs M., Writer M.J., Hailes H.C., Tabor A.B., O'callaghan C., Jaffe A., Hart S.L. A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer. Mol. Ther. 2008, 16:907-915.
74. Takahashi T., Harada A., Emi N., Kono K. Preparation of efficient gene carriers using a polyamidoamine dendron-bearing lipid: improvement of serum resistance. Bioconjug. Chem. 2005, 16:1160-1165.
75. Tal J. Adeno-associated virus-based vectors in gene therapy. J. Biomed. Sci. 2000, 7:279-291.
76. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 2000, 7:20-23.
77. Urtti A., Polansky J., Lui G.M., Szoka F.C. Gene delivery and expression in human retinal pigment epithelial cells: effects of synthetic carriers, serum, extracellular matrix and viral promoters. J. Drug Target. 2000, 7:413-421.
78. Wang G., Davidson B.L., Melchert P., Slepushkin V.A., Van Es H.H., Bodner M., Jolly D.J., Mccray P.B. Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelia. J. Virol. 1998, 72:9818-9826.
79. Wang G., Slepushkin V., Zabner J., Keshavjee S., Johnston J.C., Sauter S.L., Jolly D.J., Dubensky T.W., Davidson B.L., Mccray P.B. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Invest. 1999, 104:R55-62.
80. Weiss S.I., Sieverling N., Niclasen M., Maucksch C., Thunemann A.F., Mohwald H., Reinhardt D., Rosenecker J., Rudolph C. Uronic acids functionalized polyethyleneimine (PEI-polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriers. Biomaterials 2006, 27:2302-2312.
81. Wen Y., Pan S., Luo X., Zhang X., Zhang W., Feng M. A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector. Bioconjug. Chem. 2009, 20:322-332.
82. Wilmott R.W., Amin R.S., Perez C.R., Wert S.E., Keller G., Boivin G.P., Hirsch R., De Inocencio J., Lu P., Reising S.F., Yei S., Whitsett J.A., Trapnell B.C. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. Hum. Gene Ther. 1996, 7:301-318.
83. Yei S., Mittereder N., Wert S., Whitsett J.A., Wilmott R.W., Trapnell B.C. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 1994, 5:731-744.
84. Yew N.S., Przybylska M., Ziegler R.J., Liu D., Cheng S.H. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol. Ther. 2001, 4:75-82.
85. Zabner J., Cheng S.H., Meeker D., Launspach J., Balfour R., Perricone M.A., Morris J.E., Marshall J., Fasbender A., Smith A.E., Welsh M.J. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J. Clin. Invest. 1997, 100:1529-1537.
86. Zhang X., Godbey W.T. Viral vectors for gene delivery in tissue engineering. Adv. Drug Deliv. Rev. 2006, 58:515-534.
87. Zhou J., Wu Y., Henderson F., Mccoy D.M., Salome R.G., Mcgowan S.E., Mallampalli R.K. Adenoviral gene transfer of a mutant surfactant enzyme ameliorates pseudomonas-induced lung injury. Gene Ther. 2006, 13:974-985.
88. Zhou R., Norton J.E., Dean D.A. Electroporation-mediated gene delivery to the lungs. Methods Mol. Biol. 2008, 423:233-247.
89. Ziady A.G., Gedeon C.R., Miller T., Quan W., Payne J.M., Hyatt S.L., Fink T.L., Muhammad O., Oette S., Kowalczyk T., Pasumarthy M.K., Moen R.C., Cooper M.J., Davis P.B. Transfection of airway epithelium by stable PEGylated poly-l-lysine DNA nanoparticles in vivo. Mol. Ther. 2003, 8:936-947.
90. Zuckerman J.B., Robinson C.B., Mccoy K.S., Shell R., Sferra T.J., Chirmule N., Magosin S.A., Propert K.J., Brown-Parr E.C., Hughes J.V., Tazelaar J., Baker C., Goldman M.J., Wilson J.M. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum. Gene Ther. 1999, 10:2973-2985.